SWOG clinical trial number
SWOG-9138

Evaluation of Fazarabine for Advanced (Stage IV) Non-Small Cell Carcinoma of the Lung, Phase II

Closed
Phase
Accrual
53%
Published
Abbreviated Title
Evaluation of Fazarabine for Advanced (Stage IV) Non-Small Cell Carcinoma of the Lung, Phase II
Activated
05/15/1992
Closed
07/15/1993

Publication Information Expand/Collapse

1995

Phase II trial and cost analysis of fazarabine in advanced non-small cell carcinoma of the lung: A Southwest Oncology Group study.

SK Williamson;JJ Crowley;RB Livingston;TJ Panella;JW Goodwin Investigational New Drugs 13:67-71

1994

Phase II trial of fazarabine (FAZ) in advanced non-small cell carcinoma of the lung (NSCLC) - a clinical trial report and cost analysis: A Southwest Oncology Group study

SK Williamson;JJ Crowley;JW Goodwin;RB Livingston ASCO 13:347#(1160)